Core Viewpoint - The successful IPO of Qingsong Health Group on December 23 marks a significant step in its international capital journey and validates the commercial value of its "AI + health services + insurance" closed-loop model, injecting new momentum into China's rapidly growing digital health industry [1] Group 1: Company Overview - Qingsong Health Group, established in 2014, has transformed from an insurance technology service provider to a comprehensive digital health platform integrating health management, insurance technology, and medical services [1] - The company ranks 10th in the domestic digital comprehensive health services and health insurance services market, and 7th in the digital health services market as of 2024 [1] Group 2: Financial Performance - The company reported a revenue growth of 92.9% to 945 million yuan in 2024, achieving a substantial increase of 140% compared to 2022 [2] - For the first half of 2025, revenue further increased to 656 million yuan, reflecting a year-on-year growth of 84.7% [2] - Adjusted net profit remained above 80 million yuan for three consecutive years from 2022 to 2024, reaching 51.18 million yuan in the first half of 2025, with an 11.4% year-on-year increase [2] Group 3: Business Structure and Growth Drivers - The company has successfully transitioned from an "insurance-centric" model to one led by health services, with digital comprehensive health service revenue rising from 15.2% in 2022 to 76.7% in the first half of 2025, achieving a compound annual growth rate of 221.26% over three years [3] - The health services segment includes diverse offerings such as health content education, digital medical research assistance, comprehensive health service packages, and early disease screening promotion [3] - The insurance technology business has also seen steady growth, collaborating with 58 insurance companies to launch 294 health insurance products, with insurance technology service revenue reaching 99.44 million yuan in the first half of 2025 [3] Group 4: User Base and Engagement - As of June 2025, the company has accumulated 168.4 million registered users, with 60.4% belonging to the core health consumer group aged 20-45 [4] - The user retention rate after 13 months is 92.2%, significantly higher than the industry average, indicating strong user loyalty [4] - The conversion rate of active users to policyholders improved from 5.0‰ to 6.7‰ between 2024 and the first half of 2025, reflecting high user satisfaction with the platform's services [4] Group 5: AI Integration and Ecosystem Development - The company's core competitiveness stems from the deep integration of AI technology across various business scenarios, with its self-developed AIcare technology stack applied in multiple core areas [5] - The contribution of AI models to annualized premium value increased from 1.5% in 2022 to 23.3% in 2024, maintaining a high level of 21.3% in the first half of 2025 [5] - The introduction of the generative AI tool "Qingsong Ask Doctor Dr.GPT" in 2023 has expanded the application of AI in health services, enhancing user experience and supporting healthcare professionals [5] Group 6: Market Opportunities and Future Outlook - The IPO coincides with a golden development period for China's digital health industry, supported by increasing health awareness and favorable policies [6] - The market for comprehensive health services and health insurance is projected to reach 11.8 trillion yuan by 2029, with a compound annual growth rate of 7.7% from 2024 to 2029 [6] - The funds raised from the IPO will be used to enhance AI technology, extend health service scenarios, and integrate industry resources, aiming to strengthen the "healthcare + medicine + pharmaceuticals + wellness + insurance" ecosystem [6] Group 7: Strategic Positioning - The IPO will provide Qingsong Health Group with ample funds and resources to accelerate ecosystem expansion and technology implementation, reinforcing its leading position in the industry [7] - With ongoing technology development, enriched service scenarios, and deep user value exploration, the company is poised to become a benchmark enterprise in China's digital health industry, offering long-term and stable value returns to investors [7]

本文源自：财华网 序号代码名称涨跌额(%)最新价102635.HK诺比侃+287.75310.200202661.HK轻松健康 +116.0549.000300243.HKQPL INT'L+15.490.410401592.HK基石控股+14.710.195501102.HK环能国际 +13.950.049601233.HK时代中国控股+10.260.129700493.HK国美零售+7.690.014806698.HK星空华文 +7.341.170908401.HK源想集团+7.220.1041008462.HK中安控股集团+6.520.098 【财华社讯】12月23日早盘，截至发稿，港股涨幅榜前十名分别为诺比侃(02635.HK)涨幅287.75%、轻 松健康(02661.HK)涨幅116.05%、QPL INT'L(00243.HK)涨幅15.49%、基石控股(01592.HK)涨幅14.71%、 环能国际(01102.HK)涨幅13.95%、时代中国控股(01233.HK)涨幅10.26%、国美零售(00493.HK)涨幅 7.69%、星空华文(06698.HK)涨幅7.34%、源想集团(08401 ...

Core Viewpoint - The company "轻松健康" (Easy Health) has successfully listed its shares at a price of HKD 22.68, raising approximately HKD 513 million, with a significant initial trading increase of 120.46% to HKD 50 per share [1] Group 1: Company Overview - Easy Health provides comprehensive health and insurance solutions, including early screening, health management, health insurance, and support for medical research and public health knowledge [1] - The company aims to offer accessible, precise, and affordable health solutions to those in need [1] Group 2: Market Position - According to a report by Sullivan, Easy Health ranks 10th in China's digital integrated health services and health insurance market based on projected revenue for 2024, and 7th in the digital health services market [1] - The company was previously known as "轻松筹" (Easy Fundraising), a major online disease crowdfunding platform in mainland China, and rebranded to Easy Health Group in 2019 after obtaining an insurance brokerage license in 2016 [1]

Core Viewpoint - The Hong Kong stock market shows a mixed performance with major indices initially rising but later experiencing fluctuations, highlighting a divergence in new stock performances and a preference for quality stocks [1][2]. Group 1: Market Performance - The Hang Seng Index opened up by 0.29% at 25,875.85 points, while the Hang Seng Tech Index increased by 0.14% to 5,534.54 points [2]. - Various sectors performed well, particularly gold and chip stocks, benefiting from favorable market conditions and industry optimism [2]. - The lithium battery sector was active, with Tianqi Lithium (HK09696) opening up over 2%, and automotive stocks like Geely Automobile (HK00175) also showing strong gains, reflecting a recovery in downstream demand for the new energy industry [2]. Group 2: Individual Stock Performance - Notable individual stock movements included Dipo Technology rising by 10.15%, while Kuaishou and Smoore International saw declines of over 3% [2]. - Major tech stocks displayed mixed results, with NetEase and Meituan increasing by 0.84% and 0.88%, respectively, while Tencent and Xiaomi experienced slight pullbacks [2]. Group 3: New Stock Listings - Two significant new stocks, Nobikang (HK02635) and Lighter Health (HK02661), debuted strongly, contrasting with recent trends of new stocks underperforming [2]. - Nobikang, focused on AI applications, opened at an impressive 299.75% increase from its issue price of 80 HKD, while Lighter Health rose over 120% from its issue price of 22.68 HKD [3]. - In contrast, another new stock, Hansi Aitai-B (HK03378), struggled, with its price dropping from an issue price of 32 HKD to a low of 23 HKD [6]. Group 4: IPO Market Insights - Analysts predict a recovery in the Hong Kong IPO market by 2025, noting that nearly 70% of new stocks reported gains on their debut, although the fourth quarter has seen an increase in the rate of stocks breaking below their issue price [6].

每经AI快讯，12月23日，国内"AI+健康"赛道企业轻松健康（02661.HK）正式登陆港交所主板，股价开 盘即迎来强势表现，开盘价报50港元，较发行价高开120%。 ...

轻松健康在中国提供数字综合健康服务及健康保险解决方案。作为国内领先的综合数字健康平台，轻松 健康累计注册用户达1.684亿，60.4%为20-45岁核心消费群体，用户第13个月留存率高达92.2%。AI技术 深度赋能全业务链条，自研AIcare技术栈贡献线索价值占比超21%。同时，公司业务结构持续优化， 2025年上半年健康服务收入占比达76.7%，近三年年均复合增长率超220%，业绩增长韧性十足。 12月23日，轻松健康(2661.HK)今日首日上市高开120.46%，报50港元，市值达103亿港元。该股IPO定 价22.68港元，公开发售获1421.47倍认购，国际配售获2.9倍认购。 公司本次IPO募资将重点用于AI技术升级、健康服务场景拓展及产业链整合，持续深化"检-医-药-康- 险"生态闭环。业内人士表示，在数字健康产业万亿市场空间加持下，公司凭借稀缺商业模式与突出竞 争优势，上市后有望持续受到资金关注，为投资者带来长期回报。 港股频道更多独家策划、专家专栏，免费查阅>> 责任编辑：栎树 ...

Core Viewpoint - The digital health service provider, Easy Health (stock code: 02661.HK), made a strong debut on the Hong Kong Stock Exchange, opening at HKD 50, a significant increase of 120.46% from its issue price of HKD 22.68, reflecting high investor interest and demand [1][2]. Company Overview - Easy Health offers comprehensive digital health services and health insurance solutions in China, including disease screening promotion, health check consultation, medical appointment services, and health product sales, primarily reaching individual users through online platforms [3]. - According to a report by Sullivan, Easy Health ranks tenth in the Chinese digital comprehensive health services and health insurance market based on revenue for 2024, and seventh in the segmented digital health services market [3]. Financial Performance - The company's revenue has shown rapid growth, increasing from RMB 394 million in 2022 to RMB 945 million in 2024, representing a growth of over 140% within two years [3]. - Although the adjusted net profit fluctuated during this period, decreasing from RMB 149 million in 2022 to RMB 84 million in 2024, the financial data for the first half of 2025 indicates a recovery, with revenue reaching RMB 656 million and adjusted net profit at RMB 51 million [3].

作为港股市场稀缺的"全链条数字健康"标的，轻松健康集团的亮眼表现源于多重核心优势。用户层面， 平台累计注册用户已达1.684亿，其中60.4%为20-45岁核心健康消费群体，用户基础为业绩增长提供坚 实支撑。技术层面，自主研发的AIcare技术栈已广泛应用于内容创作、智能承保、理赔审核等核心场 景，AI模型贡献的线索价值持续提升，技术赋能成效显著。 财务数据同样亮眼，2024年公司营收同比增长92.9%至9.45亿元，2025年上半年营收再增84.7%至6.56亿 元，健康服务业务收入占比已达76.7%，成为绝对核心增长引擎。在当前港股新股市场分化加剧、稀缺 性标的受追捧的背景下，轻松健康集团凭借"AI技术+用户规模+业务闭环"的独特优势，成功吸引资金 聚焦，为后续股价表现奠定基础。保荐机构表示，公司所处赛道契合"健康中国"战略，未来增长确定性 强，有望成为港股数字健康板块的核心配置标的。 12月23日，国内"AI+健康"赛道标杆企业轻松健康集团(02661)正式登陆港交所主板。受市场对数字健康 赛道的强烈看好及公司基本面支撑，股价开盘即迎来强势表现，开盘价报50港元，较发行价高开 120%。 ...

每经AI快讯，港股轻松健康(02661.HK)首挂上市，截至发稿涨120.46%，报50港元，成交额1.38亿港 元。 ...

财务数据同样亮眼，2024年公司营收同比增长92.9%至9.45亿元，2025年上半年营收再增84.7%至6.56亿 元，健康服务业务收入占比已达76.7%，成为绝对核心增长引擎。在当前港股新股市场分化加剧、稀缺 性标的受追捧的背景下，轻松健康集团凭借"AI技术+用户规模+业务闭环"的独特优势，成功吸引资金 聚焦，为后续股价表现奠定基础。保荐机构表示，公司所处赛道契合"健康中国"战略，未来增长确定性 强，有望成为港股数字健康板块的核心配置标的。 智通财经APP获悉，12月23日，国内"AI+健康"赛道标杆企业轻松健康集团(02661)正式登陆港交所主 板。受市场对数字健康赛道的强烈看好及公司基本面支撑，股价开盘即迎来强势表现，开盘价报50港 元，较发行价高开120%。 作为港股市场稀缺的"全链条数字健康"标的，轻松健康集团的亮眼表现源于多重核心优势。用户层面， 平台累计注册用户已达1.684亿，其中60.4%为20-45岁核心健康消费群体，用户基础为业绩增长提供坚 实支撑。技术层面，自主研发的AIcare技术栈已广泛应用于内容创作、智能承保、理赔审核等核心场 景，AI模型贡献的线索价值持续提升，技术赋能成效显 ...